1. Home
  2. AEHR vs TBPH Comparison

AEHR vs TBPH Comparison

Compare AEHR & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$35.58

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$13.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
TBPH
Founded
1977
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
1.0B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
AEHR
TBPH
Price
$35.58
$13.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$21.00
$18.50
AVG Volume (30 Days)
1.6M
720.1K
Earning Date
04-08-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.88
Revenue
$58,968,000.00
$15,386,000.00
Revenue This Year
N/A
$70.90
Revenue Next Year
$60.20
N/A
P/E Ratio
N/A
$15.47
Revenue Growth
N/A
N/A
52 Week Low
$6.27
$7.90
52 Week High
$46.95
$21.03

Technical Indicators

Market Signals
Indicator
AEHR
TBPH
Relative Strength Index (RSI) 52.61 22.15
Support Level $20.22 $10.62
Resistance Level N/A $14.76
Average True Range (ATR) 4.34 0.92
MACD 0.20 -0.68
Stochastic Oscillator 46.06 5.60

Price Performance

Historical Comparison
AEHR
TBPH

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: